Darden James Matthew

Globe Life Co-Chairman & CEO Darden buys $2.2M shares while simultaneously selling $3.4M stake, net reduction.

Darden James Matthew, the Co-Chairman and CEO of Globe Life, executed a mixed trade on a single day: purchasing approximately 22,000 shares while selling roughly 22,000 shares across two transactions, netting a reduction in his overall position. The purchase price on the buy side was substantially lower than the sale prices, suggesting some tactical repositioning rather than conviction buying—he's trimming an existing stake at elevated levels while redeploying a portion into a lower entry point. Globe Life is a profitable company with steady revenue and a conservative valuation, which provides a reasonable backstop for his existing holdings. However, Darden's pattern of primarily selling (12 prior sells versus only 2 buys in his track record) and five recent GL sells dating back months signal a consistent trimming bias that reflects portfolio management rather than emerging insider confidence in a turnaround or material positive catalyst.

GL Co-Chair Darden sells 4,663 shares for $717.5K at $153.88 amid strong 11.8% 30-day run; his sells timed poorly historically (avg 90d +0.1% cross-ticker, 62.5% well-timed rate)

Darden James Matthew, GL's Co-Chairman & CEO, sold 4,663 shares at $153.88 on 2026-04-28, reducing his holdings by 7.4% to 58,451 shares. This transaction occurs after a notable 11.8% 30-day price gain and at the 52-week high of $153.97, near the top of the recent run. Examining his cross-ticker sell history, his 11 prior open-market sales averaged a 90-day return of -0.1% with a 62.5% well-timed rate, indicating his sales have historically not been reliable timing signals. At GL specifically, his prior 2 measurable sales were split (one up 5.0% and 2.7% at 30 days, one down 6.3% and 6.7% at 30 days), providing minimal historical pattern. The stock trades at a P/E of 9.67 with $1.5B quarterly revenue and solid 3.7% annual growth, but the absence of material news context and his modest historical timing success suggest the market should treat this sale as routine rebalancing by leadership rather than a bearish signal.

GL CEO Darden sells 18,318 shares at $145.10 for $2.7M, reducing holdings 26.4%; stock recently at 52-week high.

Darden James Matthew sold 18,318 shares at $145.10 on 2026-03-04, reducing his GL holdings by 26.4% to 51,093 shares. The sale occurred within 0.9% of the 52-week high of $146.95, as the stock trades at $144.75 currently and is up 10.6% over 90 days. His prior sales at GL show a mixed record: of 5 trades at this ticker, 3 prior sales (2025-07-25) had measurable 90-day outcomes with 1 of 3 well-timed, while 2 sales on 2026-02-27 (one week prior) have no outcome yet. His cross-ticker sell record shows 10 prior open-market sales with a 62.50% well-timed rate and average 90-day returns of -0.1%. The combination of substantial position reduction at elevated price levels and recent prior sales at GL warrants observation of the stock's subsequent performance against his historical patterns at this specific holding.

GL CEO Darden sold 9,527 shares at blended avg $144.34 for $1.4M on 2026-02-27; holds 58.5K post-transaction.

Darden James Matthew, Co-Chairman & CEO, executed 2 separate sales totaling 9,527 shares for $1,375,110.02, reducing his stake from 67,978 shares to 58,451 shares (-14.0%). The sales occurred at prices ($144.14 and $144.76) near the current market price of $145.26, which sits -1.2% from the 52-week high of $146.95. At the same-ticker level, Darden's prior 5 sells at GL (all executed 2025-07-25) showed mixed 90-day outcomes: 3 of 5 were well-timed (negative 90d returns, indicating the stock fell after those sales), while 2 were poorly timed (positive 90d returns). His cross-ticker sell track record demonstrates a 62.50% well-timed rate across 8 prior sales with an average 90-day return of -0.1%. GL trades at a P/E of 9.21 with $1.5B in quarterly revenue and $387.8M in net income. The transaction represents a material reduction in the CEO's personal stake at a time when the stock has recently appreciated +4.8% over 30 days and +7.8% over 90 days.

Globe Life Co-Chairman James Darden sold 33,270 shares across 5 transactions on 2025-07-25 for $4,511,095.53 (avg $135.59), reducing stake -40.0% to 49,841 shares.

Darden executed 5 separate sales totaling 33,270 shares for $4,511,095.53 at an average price of $135.59, cutting his holdings by 40% from 83,112 to 49,841 shares. The transaction occurred near the stock's 52-week high of $135.13, with prices across the sales ranging from $134.56 to $137.52. This is a material reduction in his principal position at a historically favorable valuation. Historically, Darden's prior 3 open-market sells across all tickers showed a 66.67% well-timed rate (higher = better) with +0.4% average 90-day return, while his same-ticker history shows 4 of 5 prior GL trades were well-timed at the 90-day mark. The company trades at a P/E of 10.34 with $1.5B in quarterly revenue and 6.1% annual growth, indicating a stable but value-oriented profile.

CEO Darden James Matthew sells 24.9K shares for $3.0M at Globe Life, reducing holdings by 39%

Darden James Matthew, Co-Chairman & CEO, conducted two separate sales totaling 24,890 shares for $3,024,610.22 on 2025-02-11, executing at prices of $121.29 and $121.97. This sale reduces his holdings from 63,863 shares to 38,973 shares—a 39% reduction in stake. The transaction occurred near the 52-week high ($128.40), with the stock trading at +7.6% over the past 30 days and +11.4% over 90 days, positioning the sale against a backdrop of recent strength. His prior sell at Globe Life (2023-11-03) achieved a 90-day return of +2.6%, meaning the stock continued rising after that sale—a pattern that does not align with prior well-timed exit signals. In the broader context of his cross-ticker track record, one prior sell averaged a 90d well-timed rate of 0.00%, indicating sells have not historically preceded price declines. The company trades at a P/E of 9.35 with $1.5B in quarterly revenue and a $10.2B market cap, characteristics of a mature, stable business.